SNY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This is the expense the company spent on research and development. Sanofi SA's research and development for the three months ended in Sep. 2015 was $1,521 Mil. Its research and development for the trailing twelve months (TTM) ended in Sep. 2015 was $5,932 Mil.
This is the expense the company spent on research and development.
Sanofi SA Research & Development for the trailing twelve months (TTM) ended in Sep. 2015 was 1665.84463625 (Dec. 2014 ) + 1297.61904762 (Mar. 2015 ) + 1447.81144781 (Jun. 2015 ) + 1520.76318743 (Sep. 2015 ) = $5,932 Mil.
If competitive advantage is created by a patent or tech advantage, at some point it will disappear.
High R&D usually dictates high SG&A which threatens the competitive advantage.
Sanofi SA Annual Data
|Research & Development||5,852||6,604||6,182||6,681||6,015||6,300||6,437||6,543||5,948||5,536|
Sanofi SA Quarterly Data
|Research & Development||1,578||1,709||1,575||1,614||1,477||1,666||1,298||1,448||1,521||1,486|